概括
转移性癌症患者中循环的抗瘤T细胞表现出独特的基因表达模式. 了解这些独特的转录状态对于开发新的免疫疗法至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 转移性癌症带来了重大的治疗挑战.
- 瘤透淋巴细胞 (T细胞) 在抗癌免疫中起着至关重要的作用.
- 癌症中循环T细胞的功能状态尚未完全理解.
研究的目的:
- 研究转移性癌症患者循环抗瘤T细胞的转录格局.
- 识别与转移性疾病相关的不同的T细胞状态.
- 为针对性免疫治疗策略奠定基础.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 用于分析转移性癌症患者的T细胞.
- 对循环中的T细胞进行了转录分析.
- 生物信息分析被用来识别不同的细胞群和它们的基因表达特征.
主要成果:
- 来自转移性癌症患者的循环抗瘤T细胞显示出显著的异质性.
- 在这些T细胞内确定了多种不同的转录状态.
- 特定的基因表达特征与不同的T细胞功能和疾病进展相关.
结论:
- 转移性癌症与各种循环的抗瘤T细胞状态有关.
- 这些独特的T细胞状态代表了潜在的治疗点.
- 对这些转录状态的进一步研究可能会导致改善癌症免疫疗法.
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
T Cell Activation and Clonal Selection
741
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
741
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


